Jie Ting is a seasoned professional in health economics and outcomes research (HEOR) with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Senior Director of Cell Therapy RWE & HEOR at Arcellx since August 2024, Jie Ting previously held the position of Senior Director - HTA, Value & Evidence Oncology at Pfizer from January to July 2024. Prior experience includes Senior Director and Director roles at Seagen from April 2020 to July 2024, where Jie Ting focused on global value and access initiatives. Additional experience encompasses positions at Gilead Sciences as Associate Director and Senior Manager from November 2017 to April 2020, and at Biogen as Manager and Postdoctoral Fellow in HEOR from October 2014 to October 2017. Jie Ting holds a Doctor of Philosophy (PhD) in Epidemiology from the University of North Carolina at Chapel Hill and a Master of Science in Public Health (MSPH) in Tropical Medicine from Tulane University.
This person is not in any teams
This person is not in any offices